AzTrials
AzTrials

Common Bile Duct Stones.NCT01046552

Comparison Between Pre and Intraoperative ERCP in Treatment of Common Bile Duct Stones

A study testing preoperative ERCP and LC and Intraoperative ERCP and LC in people with Common Bile Duct Stones., run by Mansoura University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

ERCP plays an important role in management of common bile duct stones. Herein the investigators compare preoperative against intraoperative ERCP. 210 were included but only 198 patients were randomly divided into two groups; PES/LC (100 patients) and LC/IOES (98 patients). Read more about this study

Who is it for?
Ages 12 to 80 years
Conditions the study is for
Common Bile Duct Stones.
What is being tested?
preoperative ERCP and LC and Intraoperative ERCP and LC
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
210 participants
Where
1 siteEgypt
Study dates
Jun 2006to Sep 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 80 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • patients with gallstones and common bile duct stones

Who cannot join

  • contraindications to ercp
  • contraindication to laparoscopy
  • biliary pancreatitis
  • refusal to participate

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ahmed Abdel-Raouf El-Geidie

    Al Mansurah, Dakahlia Governorate, 35516

Other trials in Egypt

About this study

Official title: Preoperative Versus Intraoperative Endoscopic Sphincterotomy for Management of Choledocholithiasis and Cholecystolithiasis

ERCP plays an important role in management of common bile duct stones. Herein the investigators compare preoperative against intraoperative ERCP.

210 were included but only 198 patients were randomly divided into two groups; PES/LC (100 patients) and LC/IOES (98 patients).

The total hospital stay were significantly shorter in the group of LC/IOES

Being tested
preoperative ERCP and LC, Intraoperative ERCP and LC
Keywords
Choledocholithias, Common bile duct stones, Endoscopic retrograde cholangiopancreatography, endoscopic sphincterotomy, Preoperative, intraoperative, Laparoscopic common bile duct exploration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • preoperative ERCP and LCProcedure or surgery

    preoperative ERCP followed by LC

  • Intraoperative ERCP and LCProcedure or surgery

    LC and intraoperative ERCP

Study groups in NCT01046552
Study groupRoleWhat they receive
PES/LCActive comparatorpreoperative ES followed by LC within the same hospital admission
Receives: Procedure: preoperative ERCP and LC
LC/IOESActive comparatorlaparoscopic cholecystectomy with intraoperative ercp under the same anesthesia
Receives: Procedure: Intraoperative ERCP and LC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. clearance of stones from the common bile duct

    Measured: 6 months

Secondary outcomes (1)
  1. bile duct injuries, retained stones, hospital stay, surgical time, conversion to open cholecystectomy

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2010 (estimated)
  2. Study startJun 2006
  3. Primary completionJul 2009
  4. Study completionSep 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
210 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01046552
Sponsor's protocol ID
ERCP123
Status last verified
Sep 2009
First submitted
5 Jan 2010
Last updated
12 Jan 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing preoperative ERCP and LC and Intraoperative ERCP and LC in people with Common Bile Duct Stones., run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

clearance of stones from the common bile duct (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in